NO20065038L - Anvendelse. - Google Patents

Anvendelse.

Info

Publication number
NO20065038L
NO20065038L NO20065038A NO20065038A NO20065038L NO 20065038 L NO20065038 L NO 20065038L NO 20065038 A NO20065038 A NO 20065038A NO 20065038 A NO20065038 A NO 20065038A NO 20065038 L NO20065038 L NO 20065038L
Authority
NO
Norway
Prior art keywords
compound
isomer
energy balance
negative energy
ruminants
Prior art date
Application number
NO20065038A
Other languages
English (en)
Norwegian (no)
Inventor
Jr Marcus Eugene Kehrli
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20065038L publication Critical patent/NO20065038L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20065038A 2004-05-25 2006-11-02 Anvendelse. NO20065038L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57417104P 2004-05-25 2004-05-25
PCT/IB2005/001438 WO2005115389A2 (en) 2004-05-25 2005-05-13 Specific ppar agonists for treating negative energy balance

Publications (1)

Publication Number Publication Date
NO20065038L true NO20065038L (no) 2006-12-01

Family

ID=34967765

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065038A NO20065038L (no) 2004-05-25 2006-11-02 Anvendelse.

Country Status (15)

Country Link
US (1) US20070281935A1 (pt)
EP (1) EP1753426A2 (pt)
JP (1) JP2008500323A (pt)
CN (1) CN1956719A (pt)
AR (1) AR049185A1 (pt)
AU (1) AU2005247164B2 (pt)
BR (1) BRPI0511481A (pt)
CA (1) CA2567398A1 (pt)
IL (1) IL179244A0 (pt)
MX (1) MXPA06013754A (pt)
NO (1) NO20065038L (pt)
RU (1) RU2353362C2 (pt)
TW (1) TWI280879B (pt)
WO (1) WO2005115389A2 (pt)
ZA (1) ZA200609235B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2568009A1 (en) * 2004-05-25 2005-12-08 Pfizer Products Inc. Use of ppar agonists to treat ruminants
GB0510141D0 (en) 2005-05-18 2005-06-22 Addex Pharmaceuticals Sa Novel compounds B3
ES2357992T3 (es) * 2006-12-01 2011-05-04 Actelion Pharmaceuticals Ltd. Derivados de 3-heteroaril(amino o amido)-1-(bifenil o feniltiazolil)carbonilpiperidina como inhibidores del receptor de orexina.
GB0722769D0 (en) * 2007-11-21 2008-01-02 Biolipox Ab New compounds
EP2137150A1 (en) * 2007-03-12 2009-12-30 Biolipox AB Piperidinones useful in the treatment of inflammation
ES2590482T3 (es) * 2008-12-02 2016-11-22 Dupont Nutrition Biosciences Aps Cepas y métodos para mejorar la salud y/o el rendimiento de los rumiantes
DE102009038123A1 (de) 2009-08-17 2011-02-24 Aicuris Gmbh & Co. Kg Substituierte (Thiazolyl-carbonyl)imidazolidinone und ihre Verwendung
WO2011114103A1 (en) 2010-03-18 2011-09-22 Biolipox Ab Pyrimidinones for use as medicaments
GB201314286D0 (en) 2013-08-08 2013-09-25 Takeda Pharmaceutical Therapeutic Compounds
CN116162056A (zh) * 2021-11-24 2023-05-26 上海医药工业研究院 β-catenin/BCL9蛋白-蛋白相互作用的小分子抑制剂及其应用
WO2024145931A1 (zh) * 2023-01-06 2024-07-11 上海医药工业研究院有限公司 β-catenin/BCL9蛋白蛋白相互作用的小分子抑制剂及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2340734A1 (fr) * 1976-02-13 1977-09-09 Roussel Uclaf Nouveaux derives de la m-trifluoromethylphenyl piperidine et leurs sels, procede de preparation et application a titre de medicaments
AU683121B2 (en) * 1993-12-23 1997-10-30 Novo Nordisk A/S Compounds with growth hormone releasing properties
DE10238865A1 (de) * 2002-08-24 2004-03-11 Boehringer Ingelheim International Gmbh Neue Carbonsäureamid-Verbindungen mit MCH-antagonistischer Wirkung, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
PT1567493E (pt) * 2002-11-26 2009-04-09 Pfizer Prod Inc Activadores de ppar
EP1622569B1 (en) * 2003-04-24 2015-12-02 Incyte Corporation Aza spiro alkane derivatives as inhibitors of metallproteases
CA2568009A1 (en) * 2004-05-25 2005-12-08 Pfizer Products Inc. Use of ppar agonists to treat ruminants

Also Published As

Publication number Publication date
AR049185A1 (es) 2006-07-05
CN1956719A (zh) 2007-05-02
RU2006141628A (ru) 2008-05-27
IL179244A0 (en) 2007-03-08
TWI280879B (en) 2007-05-11
RU2353362C2 (ru) 2009-04-27
TW200607501A (en) 2006-03-01
WO2005115389A3 (en) 2006-11-16
AU2005247164B2 (en) 2008-11-27
ZA200609235B (en) 2008-08-27
CA2567398A1 (en) 2005-12-08
AU2005247164A1 (en) 2005-12-08
JP2008500323A (ja) 2008-01-10
WO2005115389A2 (en) 2005-12-08
BRPI0511481A (pt) 2007-12-26
US20070281935A1 (en) 2007-12-06
EP1753426A2 (en) 2007-02-21
MXPA06013754A (es) 2007-02-08

Similar Documents

Publication Publication Date Title
NO20065038L (no) Anvendelse.
ES2186787T3 (es) Utilizacion de ritonavir (abt-538) para mejorar la farmacocinetica de medicamentos metabolizados por el citocromo p450 en un metodo de tratamiento del sida.
ES2196556T3 (es) Formulacion en granulos para el tratamiento del tracto intestinal.
CR9842A (es) Composiciones de celecoxib
WO2004066910A3 (en) Controlled release modifying complex and pharmaceutical compositions thereof
NO20040511L (no) Aminoisoxazolderivater som kinaseinhibitorer
EP4442321A3 (en) Methods of treating sjögren's syndrome using a bruton's tyrosine kinase inhibitor
US20230233506A1 (en) Method and compositions for treatment and prevention of broad spectrum virus ailments comprising a calcium channel blocker or a calmodulin blocker
CA2541813A1 (en) Methods for treating acute and overuse sprain and strain using hyaluronic acid
CA2440920A1 (en) Use of tramadol to delay ejaculation
JP2023549849A5 (pt)
JP2006503095A (ja) 反応性関節炎または滑液包炎の治療法
WO2023152682A9 (en) Contraceptive methods with scheduled bleeding effects
WO2004039822A3 (en) 4’’ - modified erythromycin derivatives
RU2008102249A (ru) Профилактический или терапевтичесский агент для корнеального /конъюнктивального заболевания
WO2022023533A3 (en) Antiviral use of liraglutide and gefitinib
HRP20041150B1 (hr) Metoda za inhibiciju atrofije ili za liječenje ili prevenciju simptoma vezanih uz atrofiju kod žena
DK0561882T3 (da) Hydroxamsyrederivater, som inhiberer lipoxygenase
TW200631579A (en) Drugs and prodrugs useful for the treatment of energy balance in ruminants
WO2003051301A3 (en) USE OF dsRNAs IN STRATEGIC THERAPEUTIC INTERVENTION OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY
DK1818052T3 (da) Anvendelse af formoterol i den profylaktiske og/eller terapeutiske behandling af muskelsvind og/eller kakektisk syndrom i forbindelse med kataboliske forhold af visse sygdomme såsom cancer, aids, infektioner, diabetes og andre
RU2006107649A (ru) Производные 2-алкилиден-19-нор-витамина d для лечения слабости, поражения мышц или саркопении
RU2004132290A (ru) Способ лечения острого иксодового клещевого боррелиоза на фоне хронического описторхоза
CO2024000737A2 (es) Anticoncepción oral con progestágeno solo
RU2007125264A (ru) Способ лечения повреждений слизистой оболочки желудочно-кишечного тракта

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application